Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity - Concepedia

Concepedia

Publication | Closed Access

Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity

60

Citations

32

References

2015

Year

Xuejun Wang, Wei Hu, Tingyu Zhang, Yingying Mao, Nannan Liu, Shengqi Wang

Antiviral Research

Potent InhibitorPharmacologyAntiviral TherapyHepatitisPharmacotherapyPolypeptide ActivityAntiviral DrugDrug DevelopmentMedicineNa+-dependent Taurocholate

References

	Year	Citations

Page 1